In atherosclerosis, berberine treatment inhibits inflammation in mouse macrophages (J774A.1) by inducing autophagy through AMPK/mTOR pathway (43) and uncoupling protein 2 in mice (44). This evidence concerns the gene UCP2 and atherosclerosis.